Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

NCT05975528 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Cellular Senescence
Sodium-Glucose Transporter 2 Inhibitors

Interventions

DRUG: SGLT2 inhibitor
DRUG: Glimepiride

Sponsor

Yonsei University